Dementia is a major threat to public health. Vascular dementia makes up to 20% of the cases of dementia and estimates of mixed dementia related to AD and vascular causes range up to 50% of cases of dementia. Vascular cognitive impairment (VCI) is the term that encompasses the clinical spectrum from mild cognitive dysfunction to vascular dementia. The NINDS Stroke Progress Review Group in 2012 cited prevention of vascular cognitive impairment as a major research priority. The pathological hallmark of VCI is white matter (WM) damage from ischemia in the periventricular regions and centrum semi vale. The imaging correlate of this WM damage is leukoaraiosis best detected by magnetic resonance imaging (MRI)/ Remote limb ischemic conditioning (RLIC) is the simple, inexpensive, and safe use of repetitive inflation of a blood pressure (BP) cuff on the arm or leg to protect distant organs such as the brain from ischemic injury. We now have exciting novel preliminary data after Bilateral Carotid Artery Stenosis (BCAS) in the mouse (model of VCI) that daily remote ischemic postcondtioning (RIPostC) using a BP cuff for 2 weeks increases CBF in a sustained fashion, improves cognitive performance, and reduces accumulation of amyloid-beta 42 protein (A42) in the brain. Our central hypothesis is that RIPostC therapy after BCAS will improve CBF and cognitive performance, and attenuate WM demyelination and brain atrophy during long-term follow up in young and aged animals, independent of sex. Our secondary hypothesis is that plasma nitrite and MRI imaging will be a useful tool to track these changes and detect responses to the therapy.
Our specific aims are:
Aim 1 : Determine if short term (1 month) and/ or long-term (4-mo) RIPostC therapy after BCAS improves long- term (6-mo) cognitive performance, and reduces WM damage in young male mice. Our published data show that short-term (2-wks) RIPostC therapy after BCAS improves CBF and cognitive performance when assessed at 28 days. 2 In this aim, mice will be followed up for up to 6-mo for behavioral outcomes.
Aim 2 : Determine if RIPostC therapy (optimal duration from Aim 1) after BCAS improves CBF, long-term (6- mo) cognitive performance, and reduces WM damage, independent of sex in aged mice. Since leukoaraiosis is predominant in aged humans of both sexes and progresses with time, we will also test long-term RIPostC treatment after BCAS in aged animals of both sexes. Animals will be followed up for 6 months.
Aim 3 : Determine the utility of humoral and imaging biomarkers as a response to RIPostC in murine BCAS model: a) the circulating humoral biomarker, plasma nitrite and b.) MRI-diffusion tensor imaging (DTI) to elucidate WM damage, and Arterial Spin Labeling (ASL) to quantify CBF. This work is the FIRST STEP to translate RIPostC therapy to humans as a safe and inexpensive therapy for vascular cognitive impairment.

Public Health Relevance

Dementia caused by vascular disease is a major cause of disability and there is no known treatment. This proposal is aimed at developing a safe, inexpensive treatment, the repetitive inflation and deflation of a blood pressure cuff on the limbs This treatment is called remote limb ischemic conditioning and we will test this treatment in young and old mice with partial obstruction of blood flow to the brain and see if it prevents worsening memory and brain damage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS090609-01A1
Application #
8986013
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Corriveau, Roderick A
Project Start
2015-07-01
Project End
2017-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Georgia Regents University
Department
Neurology
Type
Schools of Medicine
DUNS #
City
Augusta
State
GA
Country
United States
Zip Code
30912
Vaibhav, Kumar; Braun, Molly; Khan, Mohammad Badruzzaman et al. (2018) Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation. J Exp Med 215:2636-2654
Khan, Mohammad Badruzzaman; Hafez, Sherif; Hoda, Md Nasrul et al. (2018) Chronic Remote Ischemic Conditioning Is Cerebroprotective and Induces Vascular Remodeling in a VCID Model. Transl Stroke Res 9:51-63
Hess, David C; Khan, Mohammad B; Hoda, Nasrul et al. (2015) Remote ischemic conditioning: a treatment for vascular cognitive impairment. Brain Circ 1:133-139